Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Once they’ve sold they’re million for the day they should be made to back off. But on a positive they also have sold me some amazing deals to lock away and lower my cost basis so... you take the good with the bad. Can’t believe you can still get some under .20 at this point.
Now this is sticky worthy.
Can Flintstone vitamins do this?
“These statistically significant lab results strongly support Brilacidin’s prophylactic treatment potential given the drug’s potent and rapid virucidal activity—a unique ability, different from any other known drug currently in development to treat COVID-19, to inactivate the novel coronavirus prior to host cell entry and subsequent viral replication. A majority of antiviral agents targeting SARS-CoV-2 attempt to inhibit viral replication rather than completely eliminating the virus (virustatic versus virucidal). Additional time-dependent and concentration-dependent experiments are underway to further delineate Brilacidin’s virucidal properties against SARS-CoV-2”.
No. The greedy MFO is. Have to make their low risk guaranteed ROI ever month. Can’t take the foot off the pedal. Can’t wait to leave them behind when IPIX’s gets proper funding.
Self-sterilizing materials? Not only antibacterial but antiviral.
From the archives.
“We've designed oligomer and small molecule compounds that do indeed replicate the function of defensins. They're potent and broad spectrum. We've tested them against more than 25 different bacterial strains, including strains of bacteria that are resistant to antibiotics, and they work against all of them. They also have antifungal and ANTIVIRAL properties and are very inexpensive and very easy to make. They're safe, selective for bacterial cells, and don't harm mammalian cells. Polymer derivatives of these compounds have been made, and we've shown that we can add them to paints, plastics and textiles to create products and surfaces that are intrinsically and permanently self-sterilizing by virtue of the material itself”.
The man in the middle of a break down. Every day that goes by with no news it gets worse. Someone should call a doctor. Is there a doctor in the house of anonymous posters?
Nice investment strategy. A Brake down indeed is happening. Ever hear that Micheal Jackson song “man in the mirror”?
I agree and think it shows more about a person’s personality then it does about the accuracy of their predictions. But I would add that the wait could be even longer for the full story because IPIX is blessed with 3 separate trials at 3 separate labs for 3 different indications. Just because there is a chance of not helping for one doesn’t mean it won’t for the others.
Keep in mind it’s “Interim phase 1 data”.
I really appreciate your informative posts. You should nerd out on Kevetrin. Please do a deep dive. Curious what you think. Incredible potential imo. From P53 modulation to being a chemo sensitizer. Take a look if you have the time. Keep up the good posts. Challenging reads. Posts based on educated opinions are so much better than ones based on negative perceptions.
You forgot something.
“Under the terms of the License Agreement, Alfasigma made an initial upfront non-refundable payment of $0.4 million to the Company”...
The B van is loaded with a triple tank while riding on route C19. Not running out of gas for a long time...
Feel free to get off at the next rest stop.
Definitely not a crime to say so just a waste of all our time and a really bad investment strategy. Still haven’t answered my question? What do you gain by doing so?
You can’t compare P to B. Apples to oranges. B’s creation and clinical trial results are so much more robust than P was. I never liked the pivot to P. But I was willing to wait for results. B is why I really invested in the company. Speaking of investing. You know what isn’t a good investment strategy. Investing your money in a company and then going on a message board and bashing that same company instead of just keeping quiet and allowing things to play out. If your really an investor. What is to be gained by doing what you do?
Sticky worthy statement so every reader knows what they’re dealing with when they read these daily/nightly post.
“I never made any claim to be a researcher in basic science/medicine. I see patients, pure and simple”.
It’s clear now. Got Patients not Patience. Breathe from the belly. Going to be okay. 3 separate trials going on at 3 separate labs. Pretty incredible huh?
Which of the 3 labs will we hear from first? 3 trials in play. Amazing! No other trials going on outside of covid and IPIX has 3! 3 separate chances at success!!! Can anyone name another large, midsize or small company that has their drug in 3 separate trials for covid? Anyone? Maybe a doctor would know of one. Is there a doctor in the house?
Every hour! Oh the drama... get ready everybody. Every hour that passes we’ll hear more and more made up timelines from resident drama queens. Are you ready? Because if you’re not then you should be. Every second, minute and hour that passes...
Great post! That same person would have also had to deal with Polio too.
Thanks Dr. Bones for the confirmation. 3 trials. 3 labs. No one has named any other company in the same position. Not a big pharma. Not a medium size biotech. None. Just lil old IPIX chugging along. The little biotech that could save the world. What a story this will make when it’s all said and done. Against all odds.
Just trying to confirm something. These two PR’s equal 3 separate labs looking at Brilacidin. Correct? I got a very nice and courteous message saying otherwise. Not naming names! This is a nice person.
MTA for vaccine
MTA for antiviral
MTA for immunomodulatory and antiviral
WAKEFIELD, MA – March 17, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today further details on the Material Transfer Agreement (MTA) signed with a leading public health-focused U.S. university and top coronavirus expert. Under the terms of the confidential agreement, virologists plan to evaluate the potential antiviral properties of Brilacidin, the Company’s lead defensin-mimetic drug candidate, toward developing Brilacidin as a potential novel coronavirus (COVID-19) vaccine.
Vaccines containing defensins as adjuvants have been shown, both in vivo and in vitro, to activate the primary innate antiviral immune response and mediate other immunomodulatory activities against a number of viruses, including coronaviruses. Defensins and their mimetics, like Brilacidin, thus represent promising therapeutics developed as vaccines to target COVID-19, the deadly respiratory disease caused by the novel coronavirus SARS-CoV-2, which has emerged as a worldwide pandemic.
This new research is independent of that being conducted on Brilacidin at one of the U.S. 12 Regional Biocontainment Labs (RBL). The RBL is testing Brilacidin’s potential inhibitory activity as a small molecule drug against SARS-CoV-2, the novel coronavirus responsible for COVID-19.
WAKEFIELD, MA – May 5, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has executed a Material Transfer Agreement (MTA) with a leading U.S.-based Public Health Research Institute, with access to a Biosafety Level-3 (BSL-3) laboratory, to evaluate the immunomodulatory and antiviral properties of Brilacidin in relation to COVID-19. This new research is separate from the previously announced antiviral studies being conducted at a U.S. Regional Biocontainment Laboratory (RBL), which over the weekend informed us that the next phase of Brilacidin testing has commenced.
Thanks for verifying either way.
Are you talking about all those PR’s that were updating shareholders about Brilacidin going through all those trials for multiple indications? The same PR’s that have now lead IPIX to being the only phase 3 ready drug in 3 different trials in 3 separate labs for multiple indications in the fight against covid. Can you name another company in that position? Most investors and even some doctors know how long it takes to get a drug to market. Especially when your a small biotech company with the chips stacked against you. Everybody wants things yesterday. Especially children. But some have to show some maturity and have patience and allow the process to play out. Beautiful day today. Go out and enjoy! Keep on the sunny side...
And all three of those labs apparently are running around telling everyone the outcome of a small biotech company’s trial results. They’ve got a network of people they talk to. Lol! Better sticky it so everyone knows the truth! Stay healthy everyone. Don’t forget to take your flintstones and centrums.
What does the stock price have to do with finding the possible cure for a global pandemic? You believe the market knows better? Lol! This is the OTC first off. Not a real market based on market fundamentals. But even the real market hasn’t a clue. It hasn’t in years. The “market” has continued to rise while unemployment skyrocketed. The market is so detached from reality it’s not even funny. I believe in the science behind Brilacidin. This is factual not perception. The stock price will take care of itself.
Which one of the three trials? We better hope! Lol! Good stuff man.
Like clock work they appear. Quiet while it’s going up. On a red day they come out in full force. Coincidence?
Thank you for the informative response on UAVS and beyond. I will take a look at your suggestions. And keep my eye on an opening for UAVS. I didn’t think HFT’s played around in the penny world. But that was just my assumption. Have to look into that too. These penny plays can be so counterintuitive sometimes. Why some move up on merely a rumor while others who have confirmation go down. Take a stock like IPIX. Different industry but bigger potential than a say UAVS or a MVIS and still gets attacked on the daily. Even when there is confirmation on the rumors. Only pattern I see looks like some sort of manipulation going on. Goes beyond simple dilution like some are saying is the reason UAVS has fallen. Can’t make heads or tails of it. Thanks again for your thoughtful response.
Good advice. Was investigating this stock because a cast of characters keeps referencing it on MVI$ message board. I don’t own MVI$ just a watcher. I was wondering if this was the real deal or was a buy on rumor like MVI$. Not interested in rumors. Majority or those on OTC are just that. TIA
Great post! Based on all the information already out there IMO Brilacidin will play a crucial roll in returning life to “normalcy” but even if people want to believe the nonBelievers. The worst case scenario is the free data alone IPIX will receive when all said and done is worth a lot more than current share price. Cutting off years of time studying B and not having to pay one cent for it.
See sunshine. I told you it was a beautiful day. Keep on the sunny side.
Morning sunshine. Another beautiful day. Make the best of it. May the 5th be with you.
Huh? Everything ok over there?
Are you saying Princess Leo is saying “help me Oh B won! You’re are only hope”? For an increase in share price. Or Are you questioning Leo Biowalker and his decision to make a UC deal with the empire? Should he not did a deal and played his Han Solo?
Has he been a good C3EO?
What would you have done if Yoda had to make the decision?
Too positivity and beyond!
May the 4th be with you!
Great post!
And centrum. It’s a combo therapy!
I would add the time release pill to your list for the intestinal issues being seen with Covid.
Additionally I think BP was waiting to see OGEN’s OM results before proceeding. JMO.
All done at zero cost to IPIX!
“Testing Brilacidin’s direct virucidal activity on SARS-CoV-2 in human lung epithelial cells (by preincubating the novel coronavirus with Brilacidin at varying concentrations and times of incubation);
Obtaining the in vitro concentration of Brilacidin that gives half-maximal response, the EC50 value, in lung epithelial cells;
Determining impact of multiple dose exposure of Brilacidin on SARS-CoV-2 (assessing potential for achieving greater virus control without inducing toxicity);
Evaluating time-to-treatment windows as a post-exposure therapeutic (by introducing Brilacidin at 4, 8, and 16 hours post-initial infection, with virus cultures carried forward up to 48 hours);
Exploring if Brilacidin has synergistic properties with other small molecules that have antiviral activity”.
Almost Every symptom of Covid could potentially be helped by different current formulations of Brilacidin. IV drip for antiviral, anti inflammation, antibiotic and immune modulation. Time released Pills for intestinal issues. Sachets for mouth rinse for sore throat.
Nice 5 digit close. Lol! 6,000 shares in the green but only 301(?) total to bring it back down. Hopefully other people are also documenting this for future investigations. MFO’s don’t trade like this. This isn’t just dilution. This is different. Purposeful. Manipulative. Trying to break weak hands and weak minds.
I agree. I think IPIX was in sachets and time release pill mode before this. It’s been a while since they tested it in a IV form. Just pure speculation though. Rather believe that than the nefarious possibilities.
Scientists are finding Covid effecting so much more of the body than just the lungs which bodes well for B’s 3 in 1 MOA. Get it into the blood stream and let it do it’s thing.
Haha! Oh B Won!
May the 4th be with us...